US4593020A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic methods for the treatment of hangover
Assignee: Ipsen Pharma SAS
•
Filing: 1984-09-24
•
Granted: 1986-06-03
•
Expires: 2004-09-24
Abstract
Abstract This invention relates to therapeutic compositions containing betaine salts for the treatment of hangover and for the lowering of alcohol content in blood in human. Daily dose comprises oral administration of 1 to 30 g, associated with appropriate carrier. Optional ingredients are an analgesic, a buffering agent and caffeine.
Inventors
- 👤 Philippe M. Guinot
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 03:43
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505; A61K31/519; A61K31/52; A61K31/185; A61K31/205; A61K31/60; A61P; A61P9/00; A61P9/06
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
41 words
A method of treating a human in need of relief of hangover symptoms resulting from overindulgence of ethanol, said method comprising orally administering to said human a therapeutically effective amount of an admixture comprising betaine citrate and a pharmaceutically acceptable carrier.
Claim 2
Independent Claim
41 words
A method of treating a human in need of relief of hangover symptoms resulting from overindulgence of ethanol, said method comprising orally administering to said human a therapeutically effective amount of an admixture comprising betaine citrate and a pharmaceutically acceptable carrier.
Claim 3
Independent Claim
36 words
A method of treating a human suffering from symptoms associated with ethanol in the bloodstream comprising orally administering to said human a therapeutically effective amount of an admixture comprising betaine citrate and a pharmaceutically acceptable carrier.
Claim 4
Independent Claim
36 words
A method of treating a human suffering from symptoms associated with ethanol in the bloodstream comprising orally administering to said human a therapeutically effective amount of an admixture comprising betaine citrate and a pharmaceutically acceptable carrier.
Claim 5
Independent Claim
42 words
A method of treating a human in need of relief of hangover symptoms resulting from overindulgence of ethanol, said method comprising orally administering to said human an admixture comprising a therapeutically effective amount of betaine citrate together with a pharmaceutically acceptable carrier.
Claim 6
Independent Claim
42 words
A method of treating a human in need of relief of hangover symptoms resulting from overindulgence of ethanol, said method comprising orally administering to said human an admixture comprising a therapeutically effective amount of betaine citrate together with a pharmaceutically acceptable carrier.
Claim 7
Independent Claim
37 words
A method of treating a human suffering from symptoms associated with ethanol in the bloodstream comprising orally administering to said human an admixture comprising a therapeutically effective amount of betaine citrate together with a pharmaceutically acceptable carrier.
Claim 8
Independent Claim
37 words
A method of treating a human suffering from symptoms associated with ethanol in the bloodstream comprising orally administering to said human an admixture comprising a therapeutically effective amount of betaine citrate together with a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim
18 words
The method of claim 3 wherein said admixture is in the form of a tablet, capsule, or liquid.
Claim 10
Dependent Claim
20 words
The method of claim 3 wherein said betaine citrate is administered in a daily dose of 1 to 30 g.
Claim 11
Dependent Claim
20 words
The method of claim 6 wherein said betaine citrate is administered in a daily dose of 6 to 12 g.
Claim 12
Dependent Claim
20 words
The method of claim 4 wherein said betaine citrate is administered concurrently with the ingestion of ethanol by said human.
Claim 13
Independent Claim
29 words
A method of treating a human suffering from symptoms associated with ethanol in the bloodstream comprising orally administering to said human a blood alcohol reducing amount of betaine citrate.
Claim 14
Independent Claim
29 words
A method of treating a human suffering from symptoms associated with ethanol in the bloodstream comprising orally administering to said human a blood alcohol reducing amount of betaine citrate.
Claim 15
Dependent Claim
18 words
The method of claim 4 wherein said admixture is in the form of a tablet, capsule, or liquid.
Claim 16
Dependent Claim
20 words
The method of claim 4 wherein said betaine citrate is administered in a daily dose of 6 to 12 g.
Claim 17
Dependent Claim
52 words
The method of claim 1 wherein said admixture also includes one or more of (a) a pain relieving amount of analgesic selected from within the group of acetyl salicylic acid, a para-aminophenol derivative and ibuprofen, (b) an acid buffering amount of a buffering agent, and (c) an alertness inducing amount of caffeine.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-06-02 | 1989-12-02 | 1990-06-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-06-02 | 1993-12-02 | 1994-06-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-06-02 | 1997-12-02 | 1998-06-03 | $7700.00 | Window Closed / Lapsed |